一个HA茎顶着多个头作为一种新型流感疫苗
Ping Zhou1,2, Tianyi Qiu3,4, Xiang Wang5
1Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, People's Republic of China.
Emerging microbes & infections
|December 4, 2023
概括
新的仿真血凝素 (cHA) 构造,特别是cH1-H7,显示出强大的免疫性. 这种新型流感疫苗候选者引起了广泛的抗体反应,并提供了对致命病毒挑战的完整保护.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 疫苗开发 疫苗开发
背景情况:
- 经典的仿制性血凝素 (cHA) 旨在准保存的HA茎域,以获得更广泛的免疫反应.
- 将多个HA头域组合到单个茎上的免疫性对于流感疫苗潜力仍然基本上未被探索.
研究的目的:
- 设计和评估具有多个头部域的新型嵌合体血凝素 (cHA) 结构,以增强针对各种流感病毒亚型的免疫原性.
- 评估通过腺病毒载体疫苗平台传递的cH1-H7构造的保护疗效.
主要方法:
- 通过将不同流感亚型的头域合并到单个茎域,构建新的cHA (cH1-H3,cH1-H7,cH1-H3-H7,cH1-H7-H3).
- 生物信息模拟用于模拟三维结构并预测表位暴露.
- 用AdC68-cH1-H7疫苗对小鼠进行免疫接种,随后对抗体反应 (结合,中和,HAI) 和对致命流感病毒的保护进行评估.
主要成果:
- 结构分析预测了cH1-H7中暴露的中和表位,表明了免疫原性潜力.
- 接种AdC68-cH1-H7疫苗引发了高水平的结合,中和和血凝素抑制抗体,对抗流行H1N1,季节性H1N1和H7N9病毒.
- 接种疫苗的小鼠对同源和异源流感菌株的致命挑战表现出完全的保护.
结论:
- 合成的cH1-H7仿制血蛋白结构显示出显著的免疫性和广泛的保护潜力.
- AdC68-cH1-H7代表了一种有希望的新型疫苗候选人,可以提供对流感病毒的交叉亚型保护.
更多相关视频
07:55Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
Published on: August 29, 2017
11.8K
12:18Expression of Functional Recombinant Hemagglutinin and Neuraminidase Proteins from the Novel H7N9 Influenza Virus Using the Baculovirus Expression System
Published on: November 6, 2013
24.2K
相关概念视频
Vaccinations
44.6K
Overview
44.6K
Viral Recombination
23.5K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.5K
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
Cross-reactivity
31.1K
Overview
31.1K
